Integrative Medicine
RSSArticles
-
Clinical Briefs
Folate Therapy and In-Stent Restenosis and Coronary Stenting; Quinapril Reduces Markers of Oxidative Stress in the Metabolic Syndrome; Donepezil in Patients with Alzheimers -
Pharmacology Update: Estradiol Transdermal System (Menostar)
The FDA has approved a low dose estradiol transdermal patch for prevention of osteoporosis in menopausal women. -
Gastroesophageal Reflux Disease, Barrett’s Esophagus, and Esophageal Adenocarcinoma
Esophageal adenocarcinoma (EAC), GERD, and Barretts esophagus (BE) are all on the rise, and there is no doubt that BE is a major risk factor for EAC. However, many unanswered questions surround screening GERD patients for BE and cancer. -
Treatment of Depression: When Do Symptoms Go Away?
Physical symptoms are quite common among patients with depression. These symptoms tend to improve during the first month of therapy with serotonin-antagonists. Most symptoms will plateau in months to follow. -
Behind the Banning of Ephedra: Misuse, Abuse, and Dangers
Greenfield RH. Behind the banning of ephedra: Misuse, abuse, and dangers. Altern Med Alert 2004;7(3):25-33. -
Full March 2004 Issue in PDF
-
Supplement - Q&A: Food and Drug Administration’s Actions on Dietary Supplements Containing Ephedrine Alkaloids
Q&A: Food and Drug Administration's actions on dietary supplements containing ephedrine alkaloids. Altern Med Alert 2004;7(3 Suppl):S1-S2. -
Clinical Briefs: Fat Intake and Breast Cancer Risk
Greenfield RH. Fat intake and breast cancer risk. Altern Med Alert 2004;7(3):36. -
Mindfulness Meditation and Chronic Pain
Kim YH. Mindulness meditation and chronic pain. Altern Med Alert 2004;7(3):33-35. -
Pharmacology Update: Histrelin Implant (Vantas)
FDA has approved a long-acting implant for the palliative treatment of prostate cancer.